Provisional Scientific Programme
17th Meeting of the European Venous Forum
In collaboration with the UK Venous Forum, Royal Society of Medicine
London, UK, 7- 9 July 2016
Click here to download the Programme.
Click here to download the Programme/Book of Abstracts.
THURSDAY 7 JULY 2016
| 08.30-10.30 | Abstract Session 1: Risk Prediction and Superficial Vein Thrombosis (10 minute presentation, 5 minute discussion)
Chair: Andrew Bradbury (UK), Gerry Stansby (UK) |
| 08.30 Paper 1.1 | Mean platelet volume (MPV) as a predictor of venous thromboembolism (VTE) in colorectal cancer. C Wilasrusmee1, B Siribumrungwong2, N Poprom1
1Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Department of Surgery, Faculty of Medicine, Thammasat University Hospital, Thammasat University, Pathumthani, Thailand |
| 08.45 Paper 1.2 | The agreement between Caprini and Department of Health venous thromboembolism risk scores in urological patients. M Karia, S Onida, Alun H Davies
Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK Submitted for the EVF Prize |
| 09.00 Paper 1.3 | Risk adjusted DVT prophylaxis for ambulatory varicose vein procedures: How useful is the Caprini risk assessment model? AJ Wagstaff, SJ Goodyear, IK Nyamekye
The Vascular Unit, Worcestershire Royal Hospital. UK Submitted for the EVF Prize |
| 09.15 Paper 1.4 | VTE assessment scoring in patients undergoing superficial venous intervention. US and UK perspectives on risk stratification. S Onida1, M Karia1, Grant Y1, Bootun R1, Najem M2, Shalhoub J1, Davies AH1
1Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, UK; 2North West London Hospitals NHS Trust, UK Submitted for the EVF Prize |
| 09.30 Paper 1.5 | Patterns in the management of superficial vein thrombosis. C Karathanos1, K Spanos1, V Lachanas2, A Athanasoulas1, AD Giannoukas1
1 Department of Vascular Surgery, Faculty of Medicine, School of Health Sciences, University Hospital of Larissa, University of Thessaly, Larissa, Greece; 2 Department of Otorhinolaryngology, Faculty of Medicine, School of Health Sciences, University Hospital of Larissa, University of Thessaly, Larissa, Greece |
| 09.45 Paper 1.6 | Rivaroxaban for thrombosis prophylaxis in endovenous laser ablation with and without miniphlebectomy: A multicentre experience. H Uthoff1,2, D Holtz3, L Spinedi1, P Broz4, D Staub1
1 Department of Angiology, University Hospital, Basel, Switzerland; 2 Gefaesspraxis am See, St. Anna im Bahnhof, Lucerne, Switzerland; 3 Vascular Clinic, Rapperswil, Rapperswil, Switzerland; 4 Department of Angiology, Hospital of Limmattal, Limmattal, Switzerland Submitted for the EVF Prize |
| 10.00 Paper 1.7 | Treatment of superficial vein thrombosis with intermediate does of tinzaparin. The Seven study. C Karathanos1,A Giannoukas1, S Kakkos2, G Georgiadis3, C Maltezos4, M Matsagkas5, G.Papadopoulos6, C Ioannou6, K Spanos1, S Mastoraki7, S Vasdekis7, G Trelopoulos8, M Lazarides3, I Tsolakis2
1Department of Vascular Surgery, University Hospital of Larissa, Greece; 2Department of Vascular Surgery, University Hospital of Patras, Greece; 3Department of Vascular Surgery, University Hospital of Alexandroupolis, Greece; 4Department of Vascular Surgery, “KAT” Hospital, Athens, Greece; 5Vascular Surgery Unit, Department of Surgery, University Hospital of Ioannina, Greece; 6Department of Vascular Surgery, University Hospital of Heraklion, Crete, Greece; 7Department of Vascular Surgery, “ATTIKON” University Hospital, Athens; 8Vascular Surgery Unit, Department of Cardio-Thoracic Surgery, “Papanikolaou” Hospital, Thessaloniki, Greece Submitted for the EVF Prize |
| 10.15 Paper 1.8 | Deep venous stenting. A single centre experience. M Harris1, A Busuttil1,2, N Burfitt1, R Thomas1, AH Davies1,2
1Imperial College Healthcare NHS Trust, London, UK; 2Imperial College London, London, UK Submitted for the EVF Prize |
| 10.30-11.00 | Refreshments and visit to Exhibition | ePresentations Session |
| 11.00-12.00 | Didactic Session 1:
Sulodexide (Alfa Wassermann) Chairmen: Andrew Nicolaides (Cyprus), Giuseppe Maria Andreozzi (Italy) |
| 11.00 | Biomarkers in chronic venous disease and deep vein thrombosis. Ferdinando Mannello (Italy) |
| 11.15 | Sulodexide in chronic venous disease and prevention of DVT recurrence. Tomasz Urbanek (Poland) |
| 11.30 | Pharmacological rationale behind the clinical effects of Sulodexide. Jawed Fareed (USA) |
| 11.45 | Discussion Moderator: Andrew Nicolaides (Cyprus) |
| 12.00-13.00 | Didactic Session 2:
Acute DVT UK Venous Forum Chairmen: Athanasios Giannoukas (Greece), Manj Gohel (UK) |
| 12.00 | Role of D-dimer, duplex and scoring systems for VTE. Katy Darvall (UK) |
| 12.10 | Investigating DVT patients for cancer. Roshan Agarwal (UK) |
| 12.20 | Treating cancer patients with DVT. Andy Wigham (UK) |
| 12.30 | Modern treatment of acute deep vein thrombosis. Stephen Black (UK) |
| 12.40 | Discussion |
| 13.00-14.00 | Lunch and visit to Exhibition | ePresentations Session |
| 14.00-16.00 | Didactic Session 3:
UK Venous Forum and the British Association of Sclerotherapy Chairmen: Philip Coleridge-Smith (UK), Issac Nyamekye (UK) |
| 14.00 | What is the best technique of sclerotherapy for telangiectasiae and reticular varices? Albert A Ramelet (Switzerland) |
| 14.10 | Evidence for the use of compression after sclerotherapy for telangiectasiae and for saphenous trunks. Claudine Hamel-Desnos (France) |
| 14.20 | Venous symptoms and the SymVein consensus. Michel Perrin (France) |
| 14.30 | Complications of foam and liquid sclerothepray and how to avoid them. Jean-Jerome Guex (France) |
| 14.40 | Discussion |
| 15.00 | Phlebectomies vs foam for tributaries: Which is best and when. Dan Carradice (UK) |
| 15.10 | Doctor, when can I fly? Sarah Onida (UK) |
| 15.20 | Pros and cons of endovenous glue. Sudip Ray (UK) |
| 15.30 | Pros and cons of MOCA (Clarivein). Peter Holt (UK) |
| 15.40 | Discussion |
| 16.00-16.30 | Refreshments and visit to Exhibition | ePresentations Session |
| 16.30-17.30 | Didactic Session 4:
Lymphoedema (Sigvaris) Chairmen: Christine Moffat (UK), Sophie Renton (UK) |
| 17.30-18.00 | Chairman: Andrew Bradbury (UK)
Invited Key-Note Lecture The state of art, and the future of truncal ablation Lowell Kabnick, President, American Venous Forum |
| 18.00 | Welcome Reception. Exhibition Area |
FRIDAY 8 JULY 2016
| 08.30-10.30 | Abstract Session 2: Varicose Vein Ablation (10 minute presentation, 5 minute discussion)
Chair: Marianne Vandendrissche (Belgium), Ian Franklin (UK) |
| 08.30 Paper 2.1 | Endovenous heat-induced thrombosis after endovenous laser ablation with 1470 NM laser and radial fibres. OP Mandzhikian1,2,3, DN Morenko2,3,4, EA Letunovskiy1, IA Kutidze3,4, AV Zherdev1, KA Kaperiz1, AM Isaev 2,3
1“Center of Laser Surgery”, Moscow, Russia; 2“Garant Clinic”, Moscow, Russia; 3 Moscow State First Medical University Hospital #4, Moscow, Russia; 4“Plastic-C”, Korolev, Russia Submitted for the EVF Prize |
| 08.45 Paper 2.2 | Percutaneous ligation of the GSV with ultrasound guided foam sclerotherapy and miniphlebectomies. J Lawaetz, L Rasmussen
The Danish Vein Centres, Copenhagen Denmark |
| 09.00 Paper 2.3 | Novel biomatrix sclerofoam compared to endovenous laser – initial results and one year follow up. Ragg JC
Angioclinic Vein Centres – Interventional Phlebology, Berlin – Munich, Germany, – Zurich, Switzerland |
| 09.15 Paper 2.4 | The impact on residual venous reflux and varicose vein at one month follow-up on the development of recurrence of varicose vein after 5 years saphenous ablation for primary varicose vein. T Ogawa, S Hoshino
Cardiovascular Surgery, Fukushima Daiichi Hospital, Fukushima, Japan |
| 09.30 Paper 2.5 | A comparison of five year treatment outcomes in patients with and without complications of superficial venous insufficiency. J El-Sheikha, S Nandhra, C Leung, T Wallace, D Carradice, I Chetter
Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK Submitted for the EVF Prize |
| 09.45 Paper 2.6 | Mechanochemial ablation (MOCA) in patients with severe superficial vein incompetence. A prospective report. M Åkesson, A Lundell
Venous Centre, Malmö, Sweden |
| 10.00 Paper 2.7 | Randomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: The multicentre Venefit versus Clarivein for varicose veins (VVCVV) Trial. R Bootun1, TRA Lane1, B Dharmarajah1, CS Lim1,2, M Najem2, S Renton2, K Sritharan1, AH Davies1
1Academic Section of Vascular Surgery, Imperial College London, London, United Kingdom; 2Department of Vascular Surgery, North West London Hospitals NHS Trust, Harrow, United Kingdom |
| 10.15 Paper 2.8 | Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: A post-market evaluation of the venaseal system (WAVES trial). Preliminary one month data. K Gibson, on behalf of the WAVES investigators
Lake Washington Vascular Surgeons, Bellevue, Washington, USA |
| 10.30-11.00 | Refreshments and visit to Exhibition | ePresentations Session |
| 11.00-12.00 | Didactic Session 5: The place of ruscus extract + HMC + VitC in the management of chronic venous disease. (Pierre Fabre) Chairmen: Andrew Nicolaides (Cyprus), Pavel Poredos (Slovenia) |
| 11.00-11.15 | Muscarinic receptors in chronic venous disease and the effect of Ruscus. Eliete Bouskela (Brazil) |
| 11.15-11.30 | Chronic venous disease pathophysiology update. Arkadiusz Jawien (Poland) |
| 11.30-11.45 | Update on Ruscus extract + HMC + VitC comprehensive mode of action and efficacy. Francois-André Allaert (France) |
| 11.45-12.00 | Panel Discussion and Conclusions |
| 12.00-13.00 | Abstract Session 3: Cost-benefit Studies, Epidemiology and Anticoagulation Complications (10 minute presentation, 5 minute discussion)
Chair: Marianne De Maeseneer (Belgium), Keith Poskitt (UK) |
| 12.00 Paper 3.1 | A cost comparison of treating those with and without the complications of SVI. J El-Sheikha, S Nandhra, C Leung, T Wallace, D Carradice, I Chetter
Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK Submitted for the EVF Prize |
| 12.15 Paper 3.2 | The relationship between social deprivation and referral to a vascular service for the assessment and diagnosis of varicose veins and leg ulcer before and after publication of NICE Clinical Guidelines 168. H Davies, M Popplewell, A Koutsoumpelis, G Bate, A Bradbury
University of Birmingham Department of Vascular Surgery, Heart of England NHS Foundation Trust, Birmingham, UK Submitted for the EVF Prize |
| 12.30 Paper 3.3 | The prevalence of chronic venous disease worldwide. An epidiomological analysis. The final results of the vein consult programme. D Van Quickenborne1, R Colman2, S Thomis3, G Guillaume4, I Staelens5, ME Vuylsteke1
1 Department of Vascular Surgery, Sint-Andriesziekenhuis Tielt Belgium; 2 Department of Public Health, Biostatistics unit, University of Ghent, Ghent, Belgium; 3 Department of Vascular Surgery, University hospitals Leuven, Belgium; 4 Department of Cardiovascular and Thoracic Surgery, University Hospital Mont-Godinne, Belgium; 5 Department of Vascular Surgery, University Hospital of Brussels, Belgium Submitted for the EVF Prize |
| 12.45 Paper 3.4 | Bleeding risk of anticoagulants in the prevention of venous thromboembolism among Asians. NC Liew, L Lee
Department of Surgery, University Putra Malaysia, Serdang, Malaysia |
| 13.00-14.00 | Lunch and visit to Exhibition | Judging ePresentations Session
AGM of EVF (Members only) |
| 14.00-16.00 | Abstract Session 4: Investigations (10 minute presentation, 5 minute discussion)
Chair: Armando Mansilha (Portugal), Mark Whiteley (UK) |
| 14.00 Paper 4.1 | Postural change of the saphenous diameter in chronic venous disease. SK Van der Velden, M DeMaeseneer, O Pichot, T Nijsten, R van den Bos
Erasmus MC, Department of Dermatology, Rotterdam, The Netherlands Submitted for the EVF Prize |
| 14.15 Paper 4.2 | A body weight transfer manoeuvre with minimal ankle movement significantly outperforms the tip-toe manoeuvre in assessing calf muscle pump function. CR Lattimer1, E Kalodiki1, C Franceschi2, F Passariello 3
1Josef Pflug Vascular Laboratory, Ealing Hospital & Imperial College, London, UK; 2 Hôpital Paris Saint-Joseph, Paris, France; 3 Vasculab Foundation ONLUS, Napoli, Italy |
| 14.30 Paper 4.3 | Quantification of reflux volume on the great saphenous vein by duplex ultrasound in patients with primary varicosities. K Lobastov1,2, A Vorontsova1, A Bargandzhiya1, V Barinov1,2, L Laberko1, V Boyarintsev2, G Rodoman1
1The Pirogov’s Russian National Research Medical University; 2Clinical Hospital no.1 of the President’s Administration of Russian Federation, Moscow, Russia |
| 14.45 Paper 4.4 | Comparison of magnetic resonance venography and duplex scanning in the evaluation of post-thrombotic lesions of iliofemoral venous segment. M Kazakmurzaev, G Askerkhanov, M Makhatilov
Medical centre named after R.P. Askerkhanov, Makhachkala, Russia |
| 15.00 Paper 4.5 | Connexin expression in venous disease: A biomarker for venous ulceration. M Kanapathy1,2, R Simpson1, A Mosahebi1,2, D Baker1,3, D Becker4, T Richards1,3
1 Division of Surgery and Interventional Science, University College London, UK; 2 Department of Plastic Surgery, Royal Free Hospital, London, UK; 3 Department of Vascular Surgery, Royal Free Hospital, London, UK; 4 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore Submitted for the EVF Prize |
| 15.15 Paper 4.6 | Differences in levels of markers of inflammation and endothelial damage between the blood from varicose veins and systemic blood. A Spirkoska, MK Jezovnik, P Poredos
Department of Vascular Disease, University Medical Centre Ljubljana, Ljubljana, Slovenia Submitted for the EVF Prize |
| 15.30 Paper 4.7 | Cancer-relation vein thrombosis: Prevalence, causes and diagnosis. V Khryshchanovich, S Kalinin
Belarusian State Medical University, Minsk, Republic of Belarus |
| 15.45 Paper 4.8 | Wound healing disorders following endophlebectomy of the common femoral vein and its impact on the patency rates of venous recanalisation. A Gombert1, ME Barbati1, J Grommes1, RLM Kurstjens2, M. deWolf2 , C. Wittens1, H. Jalaie1
European Vascular Center Aachen-Maastricht; 1Department of Vascular Surgery University Hospital Aachen, Germany; 2 Department of Vascular Surgery University Hospital Maastricht, Netherlands Submitted for the EVF Prize |
| 16.00-16.30 | Refreshments and visit to Exhibition | Poster Session |
| 16.30-17.45 | EVF/VF Prize Sessions
Chairmen: EVF, VF Chair: Andrew Bradbury (UK), Evgeny Shaydakov (Russia) |
| 16.30-17.00 | 2 Presentations from American Venous Forum (AVF) |
| 16.30 Paper Pr. 1 |
Hybrid operative thrombectomy demonstrates non-inferiority versus percutaneous techniques for the treatment acute iliofemoral deep vein thrombosis. LE Rodriguez, R Figueroa-Vicente, A Aboukheir-Aboukheir, L Torruella-Bartolomei, J Martinez-Trabal
St. Lukes Memorial Hospital, Utica, NY, USA |
| 16.45 Paper Pr. 2 |
Is routine follow-up surveillance of iliac vein stents for iliocaval venous obstruction necessary? R Abdul-Haqq, Z Novak, B Pearce, T Matthews, M Patterson, W Jordan, M Passman
University of Alabama, Birmingham, AL, USA |
| 17.00-17.15 | 1 Presentation from American College of Phlebology (ACP) |
| 17.15 Paper Pr. 3 |
Improvement in Varicose Vein Symptoms: Quantifying with the VVSymQ, an Electronic Patient-Reported Outcome (ePRO) Instrument. N Khilnan
Interventional Radiology, NY Presbyterian Hosptial-Weill Conrell Medical College, New York, NY, USA |
| 17.15-17.45 | 2 Presentations from Japanese Society of Phlebology (JSP) |
| 17.15 Paper Pr. 4 |
Thin-slice enhanced computed tomography for delineating the right adrenal vein before adrenal venous sampling. S Onozawa
Department of Radiology, Oarai Kaigan Hospital, Ibaragi, Japan & Nippon Medical School, Tokyo, Japan |
| 17.30 Paper Pr. 5 |
Involvement of myofibroblasts in the pathophysiology of secondary lymphoedema. M Sano
Second Department of Surgery, Vascular Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan |
| 19.00 | Congress Dinner, Royal College of Surgeons |
SATURDAY 9 JULY 2016
| 08.30-10.15 | Abstract Session 5: Compression, Leg Ulceration and DVT (10 minute presentation, 5 minute discussion)
Chair: Mark Malouf (Australia), Abdusalam Abu-Own (UK) |
| 08.30 Paper 5.1 | Interface pressure, stiffness and haemodynamic effectiveness of a new compression device. G Mosti1, H Partsch2, J Damm3, T Lundh4
1Angiology Department, Clinica MD Barbantini, Lucca, Italy; 2Medical University of Vienna, Vienna, Austria; 3PressCise AB, Herrljunga, Sweden; 4Chalmers University of Technology, Gothenburg, Sweden |
| 08.45 Paper 5.2 | A method to increase working compression pressure without changing resting pressure. J Damm1, T Lundh2, Hugo Partsch3, Giovanni Mosti4
1PressCise AB, Herrljunga, Sweden; 2Chalmers University of Technology, Gothenburg, Sweden; 3Medical University of Vienna, Vienna, Austria; 4Angiology Department, Clinica MD Barbantini, Lucca, Italy |
| 09.00 Paper 5.3 | Compression film bandage added to medical compression stockings improves comfort and results of foam sclerotherapy. JC Ragg
Angioclinic Vein Centers – Interventional Phlebology, Berlin – Munich, Germany, – Zurich, Switzerland |
| 09.15 Paper 5.4 | Recalcitrant venous leg ulcers may heal by conservative outpatient treatment of venous disease even in the presence of concomitant arterial occlusive disease. G Mosti1, A Cavezzi2, H Partsch3
1Angiology Department, MD Barbantini Hospital, Lucca, Italy; 2Eurocenter Venalinfa, S. Benedetto del Tronto (AP), Italy; 3Medical University of Vienna, Vienna, Austria |
| 09.30 Paper 5.5 | Characteristics of isolated calf vein thrombos in current clinical practice. Y Hosoi, M Nunokawa, T Ikezoe, Y Nishino, H Kubota
Department of Cardiovascular Surgery, Kyorin University, Tokyo, Japan |
| 09.45 Paper 5.6 | Comparison between frequency of calf DVT after earthquakes in Japan and Italy. K Hanzawa1, T Okamoto1, K Aoki1, O Namura1, M Tsuchida1, S Stipa2, M Lugli3
1Niigata University Graduate School Of Medicine, Niigata, Japan; 2Finale Emilia, Modena, Italy; 3Hesperia Hospital, Modena, Italy |
| 10.00 Paper 5.7 | Prevalence of chronic venous disease (CVD) and restless leg syndrome (RLS) in general population (epidemiological study). A Sukhanov, K Mazaishvili, T Khlevtova, V Angelova, S Akimov, V Semkin, R Mamedov
Phlebological Centre Antireflux, Moscow, Russia |
| 10.15-10.45 | Refreshments and visit to Exhibition | Poster Session |
| 10.45-11.45 | Abstract Session 6: Deep Venous Reconstruction (10 minute presentation, 5 minute discussion)
Chair: Michel Perrin (France), Alun Davies (UK) |
| 10.45 Paper 6.1 | Pelvic vein embolization under local anaesthetic is feasible and safe in an outpatient clinic setting. 18 months’ experience of a new service. SJ Bishop, EL Davis, TJ Fernandez-Hart, P Diwakar, D Beckett, MS Whiteley
The Whiteley Clinic, London, UK |
| 11.00 Paper 6.2 | Neovalve construction surgery in postthrombotic syndrome and primary deep vein insufficiency. Y Hoshino1, S Hoshino2
1Fukuoka Sanno Hospital, Vascular Surgery, Fukuoka, Japan; 2Fukushima Diichi Hospital, Fukushima, Japan |
| 11.15 Paper 6.3 | Venous stent stability index (VSSI): A guide for iliac vein stent sizing and prevention of migration in the treatment of symptomatic iliac compression. PE Thorpe, AP Chinubhai
Arizona Heart Hospital, Phoenix, Arizona, USA Veniti Inc., Fremont, California, USA |
| 11.30 Paper 6.4 | Systematic review of open and endovascular treatment of superior vena cava syndrome of benign aetiology. GS Sfyroeras1, CN Antonopoulos1, G Mantas1, KG Moulakakis1, JD Kakisis1, E Brountzos2, CR Lattimer3, G Geroulakos1,3
1Department of Vascular Surgery; 22nd Laboratory of Radiology, University of Athens Medical School, Attikon University Hospital, Athens, Greece; 3Department of Surgery and Cancer, Imperial College, London, UK |
| 11.45-12.45 | Didactic Session 6: Deep venous interventions
Chairmen: Niels Baekgaard (Denmark), Stephen Black (UK) |
| 11.45 | Assessing outcome after venous stenting – quality of life is more important than patency. Manj Gohel (UK) |
| 11.55 | Haematological management post stenting – what anticoagulant and for how long. Prakash Saha (UK) |
| 12.05 | Deep venous valve technologies: horizon scanning. Hayley Moore (UK) |
| 12.15 | Popliteal vein entrapment: a forgotten entity. Alun Davies (UK) |
| 12.25 | Discussion |
| 12.45 | End of Meeting |